Clinical Trial Update: A Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing Spondylitis [Phase 2]

View source ↗

Summary

This Phase 2 trial update reports long-term safety and efficacy results for bimekizumab in adults with ankylosing spondylitis; the study has been completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Bimekizumab (bimekizumab)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Ankylosing Spondylitis | Phase 2 | Status: COMPLETED | Results posted: 2024-11-13